Cargando…
COVID-19 and diabetes: What does the clinician need to know?
COVID-19 and diabetes are currently two global pandemics. Epidemiological studies indicate that diabetes is the second most common comorbidity in COVID-19. This review aims to summarize currently available data about prevalence, possible pathophysiological mechanisms and management of patients with...
Autores principales: | Papadokostaki, Eleni, Tentolouris, Nikolaos, Liberopoulos, Evangelos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Primary Care Diabetes Europe. Published by Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7332931/ https://www.ncbi.nlm.nih.gov/pubmed/32654982 http://dx.doi.org/10.1016/j.pcd.2020.06.010 |
Ejemplares similares
-
Euglycemic Diabetic Ketoacidosis Secondary to Dapagliflozin in a Patient with Colon Malignancy
por: Papadokostaki, Eleni, et al.
Publicado: (2019) -
Chyluria: what does the clinician need to know?
por: Stainer, Victoria, et al.
Publicado: (2020) -
Letter to the Editor regarding ‘COVID-19 and diabetes: What does the clinician need to know?’
por: Abbasi-Oshaghi, Ebrahim, et al.
Publicado: (2021) -
Maturity-Onset Diabetes of the Young: What Do Clinicians Need to Know?
por: Kim, Sung-Hoon
Publicado: (2015) -
COVID-19 – What does a paediatrician need to know?
por: Robinson, Joan, et al.
Publicado: (2020)